Q79.69

Clinical Causes: Genetic mutations affecting collagen or other connective tissue proteins Inheritance patterns vary; most are autosomal dominant, meaning only one copy of the altered gene is sufficient to cause the disorder Some cases may result from new genetic mutations with no family history Defects in the synthesis or structure of collagen, a key protein that provides strength and elasticity to skin, joints, and blood vessels

Key Symptoms: Hyperextensible skin that can stretch more than usual Fragile skin that bruises easily and may be prone to tears or wounds Joint hypermobility, leading to frequent dislocations or subluxations Poor wound healing and thin scars Muscle weakness or fatigue Chronic pain in joints and muscles In some cases, vascular issues like easy bruising or blood vessel fragility

Diagnosis Path: Diagnosing other Ehlers-Danlos syndromes involves a combination of clinical assessment, detailed medical and family history, and sometimes genetic testing. Physicians evaluate the skin's elasticity, joint mobility, and tissue fragility. Imaging tests or biopsies may assist in ruling out other conditions. Since these syndromes are rare and diverse, a specialist familiar with connective tissue disorders often conducts the diagnosis.

Treatment Protocols: Regular follow-ups with specialists such as geneticists, rheumatologists, or dermatologists Physical therapy to strengthen muscles and improve joint stability Pain management through medications or alternative therapies Protective measures to prevent skin injuries and joint dislocations Wound care and surgical interventions when necessary Monitoring for vascular issues, especially in variants affecting blood vessels Genetic counseling for affected individuals and their families